Exemplos de uso de Prophylaxis for VTE em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Of the 727 patients presenting moderate or high risk,only 189 26% received pharmacological prophylaxis for VTE.
Whereas the total cost of prophylaxis for VTE was R$ 1,873.01, with mean cost of R$ 26.38 per patient submitted to prophylaxis at the SUS.
Even though a great number of studies show that preventive treatment is effective,albeit less than absolute, prophylaxis for VTE is still underutilized.
The use of prophylaxis for VTE was different in patients seen by the SUS and SS, even though the recommended regimen, as a whole, was similar.
Total cost and mean cost per patient were estimated as per segmentation of care received by the patient surgical procedure andhospital follow-up- including the costs of prophylaxis for VTE during hospitalization.
Primary prophylaxis for VTE has been highly recommended in the medical literature, especially after the first consensus on the subject was published in 1986.
In the SS group,98.5% 132/134 of patients performed some type of prophylaxis for VTE during hospitalization, with enoxaparin as the drug prescribed initially in 98.5% 130/132 of cases.
Prophylaxis for VTE, recommended for at least 7 days or more after high-risk surgery, has one disadvantage, because low molecular weight heparin is admitted via an injection.
Additionally, it presented yet unpublished results as to the costs of prophylaxis for VTE and incremental expenses for the health system related to the occurrence of VTE during surgical hospitalization.
In all study patients,prescription of prophylaxis for VTE before surgery was very low, both for patients submitted to abdominal surgery and to those submitted to orthopedic surgery.
The lectures covered epidemiological data on prophylaxis for medical and surgical patients,the Brazilian national guidelines on prophylaxis for VTE, the importance of daily patient assessments, and the precautions that must be taken when administering prophylactic medications.
The present study evaluated how prophylaxis for VTE is conducted in patients submitted to TKA and THA operations within the Brazilian reality, in the context of both public and private health services.
In this issue of the ABCD,Malafaia et al., describe a tool with guidelines for both risk assessment and application of methods for pharmacological and mechanical prophylaxis for VTE. It is presented as a guideline and was based on the most current techniques for making guidelines, to formulate key questions and answers, constructed on evidence-based literature pretty solid.
Currently, the recommendation is to maintain prophylaxis for VTE in patients submitted to THA and in the postoperative phase of fracture of the femur for at least four weeks, and in patients submitted to TKA, for at least ten days.
Carneiro et al. demonstrated that 86% of the surgical patient in an ICU received any type of prophylaxis for VTE. Only one study, performed in 2.000, evaluated patients submitted to THA in Brazil, demonstrating that 80% of patients were submitted to some type of drug prophylaxis. .
Most prior studies that investigated the use of prophylaxis for VTE used populations different from those assessed in our study, and were generally formed by general surgical patients or those hospitalized due to some clinical condition, demonstrating various results.
In the SUS group,87.7% 71/81 of patients received prophylaxis for VTE during hospitalization, and enoxaparin as the drug prescribed for all of them, regardless of the type of operation.
Considering the total of 71 patients that received prophylaxis for VTE during their hospital stay, the total cost of prophylaxis for the SUS was R$ 1,873.01, generating a mean cost of R$ 26.38 per patient.
OBJECTIVE The objective of this paper is to present a protocol of prophylaxis for VTE to be used in the Plastic Surgery Service of the Hospital e Maternidade Celso Pierro( HMCP)- Pontifícia Universidade Católica( PUC) de Campinas in São Paulo( SP), showing the incidence of VTE in patients undergoing abdominoplasties before and after initiation of the protocol, as well as the incidence of hematomas after a total period of 6 years.
Table 2 shows the methods used for VTE prophylaxis.
Low-dose heparin for VTE prophylaxis may be co-administered with drotrecogin alfa activated.
This evaluation revealed that low-molecular-weight heparin LMWH was not prescribed for VTE prophylaxis.
Less than 9.5% of the patients had contraindications to the use of heparin for VTE prophylaxis.
Of the cancer patients-who are, by definition, high risk-82% were prescribed heparin for VTE prophylaxis inadequately.
The primary outcome was to evaluate the venous prophylaxis adequacy based on the recommendations of the Brazilian guideline for VTE prophylaxis.
The adverse event profile reported in the ACS program is consistent with the adverse drug reactions identified for VTE prophylaxis.
Physicians may consider the potential benefits of earlier anticoagulation for VTE prophylaxis as well as the risks of post-surgical bleeding in deciding on the time of administration within this time window.
Co-administration of low-dose heparin for prophylaxis of venous thrombotic events(VTE) Low-dose heparin for VTE prophylaxis may be co-administered with drotrecogin alfa activated.
The objective of this study was to assess the effect of implementing that guideline for VTE prophylaxis on the behavior of the health care staff regarding prophylaxis for patients submitted to orthopedic or digestive tract surgery at HSL.
In 2006 Young published recommendations for VTE prophylaxis in plastic surgery16.